12 AUGUST 2004

NEW ZEALAND GAZETTE, No. 97

Guaiphenesin; except for oral use in medicines containing
2% or less or 200 milligrams or less
Haemophilus influenzae vaccine; except in oral vaccines for
the prophylaxis of bacterial complications of colds
Homatropine
Human protein C
Hyaluronic acid; in injections or implantations for tissue
augmentation or cosmetic use
Hydroquinone; except in medicines for external use
containing 2% or less
Hylan polymer; in injections or implantations for tissue
augmentation or cosmetic use
Hyoscine; except when specified elsewhere in the Schedule;
except in medicines containing 300 micrograms or less
per litre or per kilogram
Hyoscine butylbromide; except when specified elsewhere in
the Schedule
Hyoscyamine; except when specified elsewhere in the
Schedule; except in medicines containing 300 micrograms
or less per litre or per kilogram
Hyoscyamus niger; except when specified elsewhere in the
Schedule; except in medicines containing 300 micrograms
or less of total solanaceous alkaloids per litre or per
kilogram
Hypromellose; for injection except in intraocular viscoelastic
products
Ibritumomab tiuxetan
Insulins
Isosorbide dinitrate
Laronidase-rch
Levetiracetam
Levosimendan
Lignocaine; for oral use except in throat lozenges containing
30 milligrams or less per dose form; for ophthalmic use
except when used in practice by a registered optometrist;
for injection except when used as a local anaesthetic in
practice by a registered nurse or podiatrist or by a dental
therapist; for external use in medicines containing more
than 10%
Lumiracoxib
Melagatran
Memantine
Nicoumalone
Nitrofurazone
Norelgestromin
Nux vomica
Oxedrine; in medicines containing more than 30 milligrams
per recommended daily dose
Pegfilgrastim
Pemetrexed
Pneumococcal vaccine; except in oral vaccines for the
prophylaxis of bacterial complications of colds
Podophyllum emodi; for internal use; for external use for the
treatment of anogenital warts; for other external use in
medicines containing more than 20% of podophyllin
Podophyllum peltatum; for internal use; for external use for the
treatment of anogenital warts; for other external use
in medicines containing more than 20% of podophyllin
Podophyllotoxin; for internal use; for external use for the
treatment of anogenital warts; for other external use in
medicines containing more than 1%
Polyacrilamide; in injections or implantations for tissue
augmentation or cosmetic use
Polylactic acid; in injections or implantations for tissue
augmentation or cosmetic use

2439

Poractant alfa
Pramocaine
Pregabalin
Pregnenolone
Prilocaine; for injection except when used as a local
anaesthetic by a dental therapist; except when specified
elsewhere in the Schedule
Prochlorperazine; except when specified elsewhere in the
Schedule; except when sold for the treatment of nausea
associated with emergency contraception by pharmacists
or nurses accredited to sell levonorgestrel for emergency
contraception
Propantheline
Protamine sulfate
Quinisocaine
Sabadilla; except when specified elsewhere in the Schedule
Sevelamer
Strontium ranelate
Strychnos spp
Tenofovir
Thiomesterone
Thiourea; except in medicines containing 0.1% or less
Trichloroacetic acid; except for external use in medicines
containing 12.5% or less for the treatment of warts other
than anogenital warts
Vardenafil
Ximelagatran

Schedule 2
Restricted Medicines
Ciclopirox; for dermal use in medicines containing more
than 2%
Diclofenac; in solid dose form containing 25 milligrams or
less and more than 12.5 milligrams per dose form in
packs of not more than 30 tablets or capsules
Erythryl tetranitrate
*Fluconazole; for oral use in medicines which have received
the consent of the Minister or the Director-General to
their distribution as restricted medicines and are
sold in the manufacturer’s original pack containing 150
milligrams or less as a single dose for the treatment of
vaginal candidiasis
Fluorides; in pastes, gels or powders for cleaning the teeth
containing more than 0.1%
Glyceryl trinitrate; for oral or sublingual use
Haemophilus influenzae vaccine; in oral vaccines for the
prophylaxis of bacterial complications of colds
Hyoscine butylbromide; for oral use in medicines containing
not more than 10 milligrams per dose form and in packs
containing not more than 20 tablets or capsules
Mannityl hexanitrate
Pneumococcal vaccine; in oral vaccines for the prophylaxis
of bacterial complications of colds
Podophyllum emodi; for external use for the treatment
of warts other than anogenital warts in medicines
containing 20% or less and more than 10% of
podophyllin
Podophyllum peltatum; for external use for the treatment
of warts other than anogenital warts in medicines
containing 20% or less and more than 10% of
podophyllin
Podophyllotoxin; for external use for the treatment of warts
other than anogenital warts in medicines containing 1%
or less and more than 0.5%